F-18 FDG PET-positive Fibrous Dysplasia in a Patient with Intestinal Non-Hodgkin's Lymphoma

Mi, Kim Young; Kim, Hyeong Su; Kim, Jung Han; Jang, Joo Hyun; Chung, Ki Sup; Shin, Mi Kyung; Hwang, Hee Sung; Kim, Byung Chun; Jung, So Young

doi:10.4143/crt.2009.41.3.171

Cited by 8 publications

(6 citation statements)

References 13 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been numerous reports of FD, mimicking skeletal metastases, being diagnosed during work up of underlying malignancy. [ 21 22 ] In a recent study of FDG-PET imaging in FD, the average standardized uptake value (SUV) was 3.76 ± 2.40 in early images and 4.51 ± 3.07 in delayed images. A high SUV of 11.42 has been observed in FD, which is usually seen in malignancy.…”

Section: Discussionmentioning

confidence: 99%

Spinal polyostotic fibrous dysplasia in two adults: Does only biopsy unravel the mystery?

Gundgurthi

Garg

Bhardwaj

et al. 2013

Indian J Endocr Metab

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Spinal polyostotic fibrous dysplasia in two adults: Does only biopsy unravel the mystery?

Gundgurthi

Garg

Bhardwaj

et al. 2013

Indian J Endocr Metab

View full text Add to dashboard Cite

show abstract

“…It is therefore important to recognize the characteristics of this skeletal dysplasia, to allow differentiation from skeletal metastasis [6,7]. Bone lesions with 18 F-FDG uptake need to be carefully interpreted when evaluating patients with known malignancy [8]. In doubtful cases, fibrous dysplasia should be given as a differential diagnosis and histopathological diagnosis may be warranted, as highlighted in the present case (Fig.…”

mentioning

confidence: 88%

Fibrous Dysplasia Mimicking Bone Metastasis on Both Bone Scintigraphy and 18F-FDG PET-CT: Diagnostic Dilemma in a Patient with Breast Cancer

Sharma

Singh

et al. 2012

Nucl Med Mol Imaging

View full text Add to dashboard Cite

“…Bone FD lesions may present 18 F-FDG-negative (109,110) or exhibit variable degrees of 18 F-FDG activity on PET/CT, mimicking malignancy (111)(112)(113)(114)(115)(116). However, co-registration with CT enables confident characterization of lesions and avoidance of erroneous interpretation of 18 F-FDG positive skeletal findings.…”

Section: Fibrous Dysplasiamentioning

confidence: 99%

PET/CT and PET/MRI in ophthalmic oncology (Review)

et al. 2020

View full text Add to dashboard Cite

Orbital and ocular anatomy is quite complex, consisting of several tissues, which can give rise to both benign and malignant tumors, while several primary neoplasms can metastasize to the orbital and ocular space. Early detection, accurate staging and re-staging, efficient monitoring of treat-ment response, non-invasive differentiation between benign and malignant lesions, and accurate planning of external radiation treatment, are of utmost importance for the optimal and individualized management of ophthalmic oncology patients. Addressing these challenges requires the employment of several diagnostic imaging techniques, such as high-definition digital fundus photography, ultrasound imaging, optical coherence tomography, optical coherence tomography (OCT)-angiography, computed tomography (CT) and magnetic resonance imaging (MRI). In recent years, technological advances have enabled the development of hybrid positron emission tomography (PET)/CT and PET/MRI systems, setting new standards in cancer diagnosis and treatment. The capability of simultaneously targeting several cancer-related biochemical procedures using positron emitting-radiopharmaceuticals, while morphologically characterizing lesions by CT or MRI, together with the intrinsic quantitative capabilities of PET-imaging, provide incremental diagnostic information, enabling accurate, highly efficient and personalized treatment strategies. Aim of the current review is to discuss the current applications of hybrid PET/CT and PET/MRI imaging in the management of patients presenting with the most commonly encountered orbital and ocular tumors.

show abstract

F-18 FDG PET-positive Fibrous Dysplasia in a Patient with Intestinal Non-Hodgkin's Lymphoma

Cited by 8 publications

References 13 publications

Spinal polyostotic fibrous dysplasia in two adults: Does only biopsy unravel the mystery?

Spinal polyostotic fibrous dysplasia in two adults: Does only biopsy unravel the mystery?

Fibrous Dysplasia Mimicking Bone Metastasis on Both Bone Scintigraphy and 18F-FDG PET-CT: Diagnostic Dilemma in a Patient with Breast Cancer

PET/CT and PET/MRI in ophthalmic oncology (Review)

Contact Info

Product

Resources

About